GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Education » NP Life Sciences Health Industry Group Inc (OTCPK:NPLS) » Definitions » Return-on-Tangible-Equity

NP Life Sciences Health Industry Group (NP Life Sciences Health Industry Group) Return-on-Tangible-Equity : -250.00% (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is NP Life Sciences Health Industry Group Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. NP Life Sciences Health Industry Group's annualized net income for the quarter that ended in Dec. 2023 was $-0.06 Mil. NP Life Sciences Health Industry Group's average shareholder tangible equity for the quarter that ended in Dec. 2023 was $0.02 Mil. Therefore, NP Life Sciences Health Industry Group's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2023 was -250.00%.

The historical rank and industry rank for NP Life Sciences Health Industry Group's Return-on-Tangible-Equity or its related term are showing as below:

NPLS' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -105.31   Med: -78.92   Max: 61.29
Current: 61.29

During the past 6 years, NP Life Sciences Health Industry Group's highest Return-on-Tangible-Equity was 61.29%. The lowest was -105.31%. And the median was -78.92%.

NPLS's Return-on-Tangible-Equity is ranked better than
84.81% of 237 companies
in the Education industry
Industry Median: 10.29 vs NPLS: 61.29

NP Life Sciences Health Industry Group Return-on-Tangible-Equity Historical Data

The historical data trend for NP Life Sciences Health Industry Group's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NP Life Sciences Health Industry Group Return-on-Tangible-Equity Chart

NP Life Sciences Health Industry Group Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Equity
Get a 7-Day Free Trial -105.31 -78.92 -92.96 -66.67 -17.14

NP Life Sciences Health Industry Group Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 618.18 20.00 645.45 -307.07 -250.00

Competitive Comparison of NP Life Sciences Health Industry Group's Return-on-Tangible-Equity

For the Education & Training Services subindustry, NP Life Sciences Health Industry Group's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NP Life Sciences Health Industry Group's Return-on-Tangible-Equity Distribution in the Education Industry

For the Education industry and Consumer Defensive sector, NP Life Sciences Health Industry Group's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where NP Life Sciences Health Industry Group's Return-on-Tangible-Equity falls into.



NP Life Sciences Health Industry Group Return-on-Tangible-Equity Calculation

NP Life Sciences Health Industry Group's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-0.003/( (0.019+0.016 )/ 2 )
=-0.003/0.0175
=-17.14 %

NP Life Sciences Health Industry Group's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=-0.06/( (0.032+0.016)/ 2 )
=-0.06/0.024
=-250.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


NP Life Sciences Health Industry Group  (OTCPK:NPLS) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


NP Life Sciences Health Industry Group Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of NP Life Sciences Health Industry Group's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


NP Life Sciences Health Industry Group (NP Life Sciences Health Industry Group) Business Description

Traded in Other Exchanges
N/A
Address
4125 Blackhawk Plaza Circle, Suite 166, Danville, CA, USA, 94506
NP Life Sciences Health Industry Group Inc offers international study tours, online and offline, in classical Chinese studies through classes, lectures, cultural, and artistic events. Its revenues are comprised of providing promotions and consulting services to its partner who gives international study tour services, commission to be received from partner enrollment services and mental health consulting services.
Executives
Guidong Wang director, 10 percent owner, officer: Chairman, CEO. Pres, Treas 4125 BLACKHAWK PLAZA CIRCLE, SUITE 168, DANVILLE CA 94506
Huaying Zhu director, officer: Secretary 4125 BLACKHAWK PLAZA CIRCLE, SUITE 168, DANVILLE CA 94506
Jonathan Ginsberg director 4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE CA 94506
Sanjun Kuang director, officer: CEO, President and Treasurer 4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE CA 94506
Meisang Hu director, 10 percent owner 4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE CA 94506
Huawei Li director, officer: Secretary 4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE CA 94506
Jianhua Wang 10 percent owner 4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE CA 94506

NP Life Sciences Health Industry Group (NP Life Sciences Health Industry Group) Headlines

No Headlines